What is the analyst consensus rating for ABBV?

The analyst consensus rating for ABBV is "Hold" based on 23 analyst recommendations.

What is the average price target for ABBV?

The average 12-month price target for ABBV is $245.82, representing an upside of 5.6% from the current price of $232.86.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

AbbVie Inc. (ABBV) Forecast: Analyst Ratings & Targets

Latest ABBV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Feb 4, 2026	PerPlexity Drug Manufacturers - General	TipRanks - PerPlexity	Reiterates	Hold	$228.00 → $245.00 +17.00 (7.5%)
Feb 4, 2026	Edmund Ingham	Forbes	Initiates Coverage	Hold	-
Feb 2, 2026	David Amsellem	Piper Sandler	Reiterates	Buy	$289.00
Jan 28, 2026	Asad Haider	Goldman Sachs	Maintains	Hold	$223.00
Jan 28, 2026	Geoff Meacham	Citi	Maintains	Hold	$235.00 → $230.00 -5.00 (-2.1%)
Jan 28, 2026	Terence Flynn	Morgan Stanley	Maintains	Buy	$269.00
Jan 27, 2026	Geoff Meacham	Citi	Maintains	Hold	$235.00 → $230.00 -5.00 (-2.1%)
Jan 21, 2026	Mohit Bansal	Wells Fargo	Maintains	Buy	$260.00
Jan 20, 2026	Courtney Breen	Bernstein	Maintains	Hold	$203.00 → $225.00 +22.00 (10.8%)
Jan 19, 2026	Luisa Hector	Berenberg Bank	Maintains	Buy	$270.00 → $275.00 +5.00 (1.9%)
Jan 16, 2026	Jason Gerberry	BofA Securities	Reiterates	Hold	$233.00
Jan 15, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$258.00
Jan 13, 2026	David Risinger	Leerink Partners	Maintains	Buy	-
Jan 9, 2026	Rajesh Kumar	HSBC	Maintains	Buy	$265.00
Jan 8, 2026	Alexandria Hammond	Wolfe Research	Downgrades	Hold	-
Jan 7, 2026	Michael Yee	UBS	Initiates	Hold	$220.00 → $240.00 +20.00 (9.1%)
Jan 1, 2026	Mike Zaccardi, CFA, CMT	Investing.com	Initiates Coverage	Buy	-
Dec 30, 2025	Sundeep Ganoria	Zacks Equity Research	Initiates Coverage	Buy	-
Dec 23, 2025	Kinjel Shah	Zacks Equity Research	Initiates Coverage	Buy	-
Dec 18, 2025	David Amsellem	Piper Sandler	Reiterates	Buy	$289.00
Dec 17, 2025	Gavin Clark-Gartner	Evercore ISI Group	Maintains	Buy	$222.00 → $233.00 +11.00 (5.0%)
Dec 12, 2025	Terence Flynn	Morgan Stanley	Maintains	Buy	$261.00 → $269.00 +8.00 (3.1%)
Dec 10, 2025	Rajesh Kumar	HSBC	Upgrades	Strong Buy	$225.00 → $265.00 +40.00 (17.8%)
Dec 10, 2025	Mohit Bansal	Wells Fargo	Maintains	Buy	$260.00
Dec 9, 2025	PerPlexity Drug Manufacturers - General	TipRanks - PerPlexity	Reiterates	Hold	$229.00 → $228.00 -1.00 (-0.4%)
Dec 9, 2025	Anthropic Drug Manufacturers - General	TipRanks - Anthropic	Reiterates	Hold	$217.00 → $231.00 +14.00 (6.5%)
Dec 9, 2025	DeepSeek Drug Manufacturers - General	TipRanks - DeepSeek	Reiterates	Hold	$217.00 → $229.00 +12.00 (5.5%)
Dec 9, 2025	xAi Drug Manufacturers - General	TipRanks - xAI	Reiterates	Hold	$222.00 → $233.00 +11.00 (5.0%)
Dec 9, 2025	OpenAI Drug Manufacturers - General	TipRanks - OpenAI	Reiterates	Hold	$243.00 → $241.00 -2.00 (-0.8%)

PerPlexity Drug Manufacturers - General

TipRanks - PerPlexity

HoldReiterates

$228.00 → $245.00

Feb 4

Edmund Ingham

Forbes

HoldInitiates Coverage

Feb 4

David Amsellem

Piper Sandler

BuyReiterates

$289.00

Feb 2

Asad Haider

Goldman Sachs

HoldMaintains

$223.00

Jan 28

Geoff Meacham

Citi

HoldMaintains

$235.00 → $230.00

Jan 28

Terence Flynn

Morgan Stanley

BuyMaintains

$269.00

Jan 28

Geoff Meacham

Citi

HoldMaintains

$235.00 → $230.00

Jan 27

Mohit Bansal

Wells Fargo

BuyMaintains

$260.00

Jan 21

Courtney Breen

Bernstein

HoldMaintains

$203.00 → $225.00

Jan 20

Luisa Hector

Berenberg Bank

BuyMaintains

$270.00 → $275.00

Jan 19

Jason Gerberry

BofA Securities

HoldReiterates

$233.00

Jan 16

Evan Seigerman

BMO Capital

BuyMaintains

$258.00

Jan 15

David Risinger

Leerink Partners

BuyMaintains

Jan 13

Rajesh Kumar

HSBC

BuyMaintains

$265.00

Jan 9

Alexandria Hammond

Wolfe Research

HoldDowngrades

Jan 8

Michael Yee

UBS

HoldInitiates

$220.00 → $240.00

Jan 7

Mike Zaccardi, CFA, CMT

Investing.com

BuyInitiates Coverage

Jan 1

Sundeep Ganoria

Zacks Equity Research

BuyInitiates Coverage

Dec 30

Kinjel Shah

Zacks Equity Research

BuyInitiates Coverage

Dec 23

David Amsellem

Piper Sandler

BuyReiterates

$289.00

Dec 18

Gavin Clark-Gartner

Evercore ISI Group

BuyMaintains

$222.00 → $233.00

Dec 17

Terence Flynn

Morgan Stanley

BuyMaintains

$261.00 → $269.00

Dec 12

Rajesh Kumar

HSBC

Strong BuyUpgrades

$225.00 → $265.00

Dec 10

Mohit Bansal

Wells Fargo

BuyMaintains

$260.00

Dec 10

PerPlexity Drug Manufacturers - General

TipRanks - PerPlexity

HoldReiterates

$229.00 → $228.00

Dec 9

Anthropic Drug Manufacturers - General

TipRanks - Anthropic

HoldReiterates

$217.00 → $231.00

Dec 9

DeepSeek Drug Manufacturers - General

TipRanks - DeepSeek

HoldReiterates

$217.00 → $229.00

Dec 9

xAi Drug Manufacturers - General

TipRanks - xAI

HoldReiterates

$222.00 → $233.00

Dec 9

OpenAI Drug Manufacturers - General

TipRanks - OpenAI

HoldReiterates

$243.00 → $241.00

Dec 9

AbbVie (ABBV) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest ABBV Analyst Ratings & Recommendations